JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?" Related Content: Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?
The Black Market for Investigational GLP-1 Drugs
JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain." Related Content: Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Barg ...Show more
An opioid abuse epidemic now plagues US healthcare. It was caused, in part, by overzealous advocacy for controlling chronic pain resulting in overuse of narcotics. There are now 2 million Americans addicted to opioids. The approach for treating chronic pain must change. In this p ...Show more
The first U.S. measles death in nearly a decade has been reported at a Texas children’s hospital, as health officials race to contain the outbreak. The Supreme Court appeared poised to side with an Ohio woman in her bid to revive a lawsuit alleging "reverse discrimination" after ...Show more
Drug overdose deaths are on the rise all around the country, including in Chicago, Illinois. ProPublica Illinois reporter Duaa Eldeib explains how the coronavirus pandemic has exacerbated the opioid epidemic, and the challenges that public health officials are facing as they work ...Show more